MGMT and glioblastoma: (Hyper-)methylation of the MGMT promoter (O6-Methylguanin DNA-Methyltransferase), a gene encoding a DNA repair protein removing alkyl adducts, constitutes a favourable factor in glioblastoma response to temozolomide [6].